Form 4: Integra LifeSciences Executive McBreen Reports Stock Transactions
SEC Form 4 Filing
EVP & President, CSS, Michael J. McBreen, reports acquisition and disposal of Integra LifeSciences Holdings Corp stock and stock options on March 11, 2025.
Summary
- Michael J. McBreen, EVP & President, CSS of Integra LifeSciences Holdings Corp, filed a Form 4 on March 13, 2025, reporting transactions in the company's stock.
- On March 11, 2025, McBreen disposed of 446 shares of common stock at $23.95 and another 1,587 shares at $23.95.
- Also on March 11, 2025, McBreen acquired 18,480 shares of common stock at $0.
- Following these transactions, McBreen beneficially owns 70,344 shares of common stock.
- McBreen also acquired 39,132 non-qualified stock options with an exercise price of $23.95, vesting in four equal installments annually from March 11, 2025, and expiring on March 11, 2033.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of insiders.
Stakeholder Impact
- The reported transactions provide shareholders with insight into the executive's stock ownership and trading activity.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date of stock and stock option transactions. |
| 03/11/2033 | Expiration date of non-qualified stock options. |
| 03/13/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.